Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon
Completed
- Conditions
- HIV Infections
- Interventions
- Drug: Treatment initiation for HIV-1 group O infected patientsDrug: Treatment initiation for HIV-1 group M infected patients
- First Posted Date
- 2008-04-15
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 141
- Registration Number
- NCT00658346
- Locations
- 🇨🇲
Hôpital Central, Yaounde, Cameroon
🇨🇲Hôpital de la CNPS, Yaounde, Cameroon
Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Phase 3
Completed
- Conditions
- HIV Infections
- Interventions
- Biological: GenHevac B Pasteur
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2013-07-23
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 437
- Registration Number
- NCT00480792
- Locations
- 🇫🇷
Hopital Cochin CIC de vaccinologie, Paris, France
Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Phase 2
Completed
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 105
- Registration Number
- NCT00424814
- Locations
- 🇫🇷
Hopital Pitie salpetriere, Paris, France
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
Phase 2
Completed
- Conditions
- Liver FibrosisHepatitis C, Chronic
- Interventions
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2014-09-04
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 372
- Registration Number
- NCT00323804
- Locations
- 🇫🇷
Service d'Hépatogastroentérologie - CH La Roche sur Yon, La Roche sur Yon, France
🇫🇷Service d'Hépatogastroentérologie - CH Montélimar, Montelimar, France
🇫🇷Centre Hospitalier, Saint Quentin, France
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2014-02-07
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 166
- Registration Number
- NCT00265642
- Locations
- 🇫🇷
CHU Angers, Service d'hépato-gastroentérologie, Angers, France
Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Phase 3
Completed
- Conditions
- Carcinoma, HepatocellularHepatitis, Viral, Human
- Interventions
- Drug: 131 I-lipiodol
- First Posted Date
- 2005-06-30
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 73
- Registration Number
- NCT00116454
- Locations
- 🇫🇷
Service d'Hépatologie Hôpital Saint Antoine, Paris, France
© Copyright 2025. All Rights Reserved by MedPath